Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPLIFY: De-escalation vs. Continued Antipseudomonal Treatment for Enterobacteriaceae Bacteremia
NCT02795949Phase 3Completed
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Oct 2016
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Bacteremia (2 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Clinical cure at day 3-5 after treatment. Started Oct 2016; status: completed.
02
Conditions
Bacteremia
Beyond the preview
Go deeper on NCT02795949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02795949.